Project Details
Description
A randomized, double-blind, placebo- controlled study of LMN-201 for prevention of C. difficile infection recurrence (RePreve)
| Status | Active |
|---|---|
| Effective start/end date | 6/5/24 → 6/5/35 |
Funding
- Lumen Biomedical, Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.